Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction
NCT07020559Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of allogeneic platelet-rich plasma in diabetic foot ulcer (DFU), sponsored by Peking University Third Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
allogeneic platelet-rich plasma
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07020559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07020559.